< Back to scientific publications

Magazine 5.1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors

Authors: Benedetta Stefanini et al

Date: 22 Nov 2023

Scope of interest: hepatological




You may also be interested in:

Magazine 4,672

Association of Hormonal Dysregulation with Metabolic Syndrome in Older Women (Data from the InCHIANTI Study)

Authors: May M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM, Ferrucci L

Date: 2007

Scope of interest: endocrinology, physiology


Read details
Report/Poster of Convention/Congress Act

Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS-Cov-2 infection

Authors: D’Amico C. et al.

Date: 2022

Scope of interest: Transfusion Medicine


Read details
Magazine 10,859

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from THE STUDY

Authors: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G

Date: 2015

Scope of interest: metabolism, diabetes


Read details